Corrigendum to "PEI-PEG-Coated Mesoporous Silica Nanoparticles Enhance the Antitumor Activity of Tanshinone IIA and Serve as a Gene Transfer Vector". [PDF]
Evid Based Complement Alternat MedZhu Y +6 more
europepmc +1 more source
Integrating network pharmacology and molecular docking to explore the pharmacological mechanism of tanshinone IIA in improving chronic obstructive pulmonary disease. [PDF]
Medicine (Baltimore)Liu H, Yang S, Chen B, Shao S, Zhang X.
europepmc +1 more source
In silico identification and verification of Tanshinone IIA-related prognostic genes in hepatocellular carcinoma. [PDF]
Front ImmunolQian L +8 more
europepmc +1 more source
[Retracted] Tanshinone IIA improves hypoxic ischemic encephalopathy through TLR‑4‑mediated NF‑κB signal pathway. [PDF]
Mol Med RepFang C +6 more
europepmc +1 more source
Retraction: Exploration of multiple signaling pathways through which sodium tanshinone IIA sulfonate attenuates pathologic remodeling experimental infarction. [PDF]
Front PharmacolFrontiers Editorial Office.
europepmc +1 more source
Network Pharmacology, Molecular Docking, and in vitro Experiments Reveal the Role and Mechanism of Tanshinone IIA in Colorectal Cancer Treatment Through the PI3K/AKT Pathway. [PDF]
Drug Des Devel TherSun J +8 more
europepmc +1 more source
Correction: Retraction: Tanshinone IIA Inhibits HIF-1α and VEGF Expression in Breast Cancer Cells via mTOR/p70S6K/RPS6/4E-BP1 Signaling Pathway. [PDF]
PLoS OnePLOS One Editors.
europepmc +1 more source
Tanshinone IIA Protects Ischemia/Reperfusion-Induced Cardiomyocyte Injury by Inhibiting the HAS2/FGF9 Axis. [PDF]
Cardiol Res PractWang Y +7 more
europepmc +1 more source
Retraction: Tanshinone IIA inhibits HIF-1α and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway. [PDF]
PLoS OnePLOS One Editors.
europepmc +1 more source